Role of PLP-Level as a predictive marker for oral health status in adult hypophosphatasia.


Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
08 Jul 2024
Historique:
received: 04 05 2024
accepted: 28 06 2024
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: epublish

Résumé

The aim of this study was to investigate the role of pyridoxal-5-phosphate (PLP) level on the oral health status as a predictive marker in patients with hypophosphatasia (HPP). Throughout a systematic retrospective assessment both bone metabolism and oral health status were analyzed. The oral health status was assessed by the decayed/missing/filled teeth index (DMFT), clinical attachment level (CAL), probing pocket depth (PPD), and the periodontal screening index (PSI). A total of 48 HPP patients (81.3% female) with a mean age of 42.21 years was included in this retrospective study. The study population was divided into two groups using the mean PLP level (87 µg/l) as a cut-off. Patients with a PLP level ≥ 87 µg/l (n = 14) showed a significantly poorer oral health status regarding DMFT index, CAL, PPD and PSI compared to patients with a PLP level < 87 µg/l (n = 34). No significant group differences for tooth loss were found. The results of the present study indicate that the PLP level is a suitable diagnostic predictor for the oral health status in HPP patients. HPP patients with PLP levels ≥ 70 µg/l should be included into a regular dental preventive program. The oral health status in HPP and its correlation with laboratory parameters (i.e. PLP) has been understudied. For clinical practice, the findings of the present study clearly demonstrated that high PLP levels correlate with a worse oral health status in HPP patients. Therefore, these patients should receive an intensive dental treatment and/or inclusion in a strict maintenance program in a specialized dental practice/university hospital with a PLP level ≥ 70 µg/l.

Identifiants

pubmed: 38976034
doi: 10.1007/s00784-024-05809-w
pii: 10.1007/s00784-024-05809-w
doi:

Substances chimiques

Biomarkers 0
Pyridoxal Phosphate 5V5IOJ8338

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

419

Informations de copyright

© 2024. The Author(s).

Références

Fenn JS, Lorde N, Ward JM, Borovickova I, Hypophosphatasia (2021) J Clin Pathol. 74(10):635–640, https://doi.org/10.1136/jclinpath-2021-207426 . PMID: 33931563
Tournis S, Yavropoulou MP, Polyzos SA, Doulgeraki A, Hypophosphatasia (2021) J Clin Med. 10(23):5676, https://doi.org/10.3390/jcm10235676 . PMID: 34884378
Mornet E, Hypophosphatasia (2007) Orphanet J Rare Dis. 2:40, https://doi.org/10.1186/1750-1172-2-40 . PMID: 17916236
Akiyama T, Kubota T, Ozono K, Michigami T, Kobayashi D, Takeyari S, Sugiyama Y, Noda M, Harada D, Namba N, Suzuki A, Utoyama M, Kitanaka S, Uematsu M, Mitani Y, Matsunami K, Takishima S, Ogawa E, Kobayashi K (2018) Pyridoxal 5’-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy. Mol Genet Metab. 125(1–2):174–180, https://doi.org/10.1016/j.ymgme.2018.07.006 . PMID: 30049651
Bangura A, Wright L, Shuler T, Hypophosphatasia (2020) Current Literature for Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment. Cureus. 12(6):e8594, https://doi.org/10.7759/cureus.8594 . PMID: 32676235
Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 54(1):21 – 7, https://doi.org/10.1016/j.bone.2013.01.024 . PMID: 23352924
Okawa R, Nakano K (2022) Dental manifestation and management of hypophosphatasia. Jpn Dent Sci Rev. 58:208–216, https://doi.org/10.1016/j.jdsr.2022.06.002 . PMID: 35814738
Hughes SL, Parkes RC, Drage N, Collard M (2017) Early Tooth Loss in Children: A Warning Sign of Childhood Hypophosphatasia. Dent Update. 44(4):317-8, 320-1, https://doi.org/10.12968/denu.2017.44.4.317 . PMID: 29172356
Mori M, DeArmey SL, Weber TJ, Kishnani PS (2016) Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? - Call for a long-term follow-up of premature loss of primary teeth. Bone Rep. 5:228–232, https://doi.org/10.1016/j.bonr.2016.08.004 . PMID: 28580391
Weider M, Schlagenhauf U, Seefried L (2022) Oral health status of adult hypophosphatasia patients: A cross-sectional study. J Clin Periodontol. 49(12):1253–1261, https://doi.org/10.1111/jcpe.13718 . PMID: 36054522
Caruso S, Bernardi S, Pasini M, Giuca MR, Docimo R, Continenza MA, Gatto R (2016) The process of mineralisation in the development of human tooth. Eur J Paediatr Dent 17(4):322–326 PMID: 28045323
pubmed: 28045323
Okawa R, Nakamoto T, Matayoshi S, Nakano K, Kakimoto N (2022) Evaluation of alveolar bone hypomineralization in pediatric hypophosphatasia using orthopantomography. Sci Rep. 12(1):1211, https://doi.org/10.1038/s41598-022-05171-5 . PMID: 35075203
Hu JC, Plaetke R, Mornet E, Zhang C, Sun X, Thomas HF, Simmer JP (2000) Characterization of a family with dominant hypophosphatasia. Eur J Oral Sci. 108(3):189 – 94, https://doi.org/10.1034/j.1600-0722.2000.108003189.x . PMID: 10872988
Bloch-Zupan A, Vaysse F (2017) Hypophosphatasia: oral cavity and dental disorders. Arch Pediatr. 24(5S2):5S80-5S84, https://doi.org/10.1016/S0929-693X(18)30020-4 . PMID: 29405938
Popescu M, Ionescu M, Scrieciu M, Popescu SM, Mercuţ R, Amărăscu MO, Iacov Crăiţoiu MM, Lazăr D, Mercuţ V (2022) Etiology Study of Acquired Developmental Defects of Enamel and Their Association with Dental Caries in Children between 3 and 19 Years Old from Dolj County, Romania. Children (Basel). 9(9):1386, https://doi.org/10.3390/children9091386 . PMID: 36138695
Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M’Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM (2024) Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. ;35(3):431–438. https://doi.org/10.1007/s00198-023-06844-1 . Epub 2023 Nov 20. Erratum in: Osteoporos Int. 2024;35(5):933–934. PMID: 37982857
El Maghraoui A, Roux C (2008) DXA scanning in clinical practice. QJM. ;101(8):605 – 17. https://doi.org/10.1093/qjmed/hcn022 . Epub 2008 Mar 10. PMID: 18334497
Carey JJ, Delaney MF, Love TE, Richmond BJ, Cromer BA, Miller PD, Manilla-McIntosh M, Lewis SA, Thomas CL, Licata AA (2007) Oct-Dec;10(4):351-8 DXA-generated Z-scores and T-scores may differ substantially and significantly in young adults. J Clin Densitom. https://doi.org/10.1016/j.jocd.2007.06.001 . Epub 2007 Jul 26. PMID: 17662630
Holtfreter B, Albandar JM, Dietrich T, Dye BA, Eaton KA, Eke PI, Papapanou PN, Kocher T, Joint EUUSA, Periodontal Epidemiology Working Group (2015). Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed standards from the Joint EU/USA Periodontal Epidemiology Working Group. J Clin Periodontol. 42(5):407 – 12, https://doi.org/10.1111/jcpe.12392 . PMID: 25808877
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015). Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17(5):405 – 24, https://doi.org/10.1038/gim.2015.30 . PMID: 25741868
Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ (2012) Update of the case definitions for population-based surveillance of periodontitis. J Periodontol. 83(12):1449-54, https://doi.org/10.1902/jop.2012.110664 . PMID: 22420873
Ahmed MA, Jouhar R, Faheemuddin M, AlJafar A, Alabawi H, Alhumaidi B, Al Madeh M (2023) Assessment of Oral Health Knowledge, Attitude, Practice and DMFT Scores among Patients at King Faisal University, Al-Ahsa. Medicina (Kaunas). 59(4):688, https://doi.org/10.3390/medicina59040688 . PMID: 37109646
Jordan RA, Bodechtel C, Hertrampf K, Hoffmann T, Kocher T, Nitschke I, Schiffner U, Stark H, Zimmer S, Micheelis W, DMS V Surveillance Investigators’ Group (2014). The Fifth German Oral Health Study (Fünfte Deutsche Mundgesundheitsstudie, DMS V) - rationale, design, and methods. BMC Oral Health. 14:161, https://doi.org/10.1186/1472-6831-14-161 . PMID: 25547464
Jordan AR, Micheelis W, Cholmakow-Bodechtel C, Füßl-Grünig E, Geyer S, Hertrampf K, Hoffmann T, Holtfreter B, Kocher T, Nitschke I, Noffz S, Scharf L, Schiffner U, Schützhold S, Stark H, Zimmer S (2016) Fünfte Deutsche Mundgesundheitsstudie (DMS V). Deutscher Zahnärzte Verlag DÄV
Nunes ME, Hypophosphatasia (2007) Nov 20 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews
Sinha P, Gabor R, Haupt-Harrington R, Deering L, Steiner RD (2022) Dental manifestations in adult hypophosphatasia and their correlation with biomarkers. JIMD Rep. 63(5):434–445, https://doi.org/10.1002/jmd2.12307 . PMID: 36101824
Wölfel EM, von Kroge S, Matthies L, Koehne T, Petz K, Beikler T, Schmid-Herrmann CU, Kahl-Nieke B, Tsiakas K, Santer R, Muschol NM, Herrmann J, Busse B, Amling M, Rolvien T, Jandl NM, Barvencik F (2023) Effects of Infantile Hypophosphatasia on Human Dental tissue. Calcif Tissue Int 112(3):308–319 Epub 2022 Nov 21. PMID: 36414794; PMCID: PMC9968273
doi: 10.1007/s00223-022-01041-4 pubmed: 36414794
Haliloglu B, Guran T, Atay Z, Abali S, Mornet E, Bereket A, Turan S (2013) Infantile loss of teeth: odontohypophosphatasia or childhood hypophosphatasia. Eur J Pediatr 172(6):851–853. https://doi.org/10.1007/s00431-012-1868-4 [PubMed] [CrossRef] [Google Scholar]
doi: 10.1007/s00431-012-1868-4 pubmed: 23093139
Hartsfield JK Jr (1994) Premature exfoliation of teeth in childhood and adolescence. Adv Pediatr.41:453 – 70, PMID: 7992695
Genest F, Claußen L, Rak D, Seefried L (2021) Bone mineral density and fracture risk in adult patients with hypophosphatasia. Osteoporos Int 32(2):377–385. https://doi.org/10.1007/s00198-020-05612-9 Epub 2020 Sep 2. PMID: 32879991
doi: 10.1007/s00198-020-05612-9 pubmed: 32879991
Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, Rüther W, Amling M, Barvencik F (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28(9):2653–2662. https://doi.org/10.1007/s00198-017-4087-z
doi: 10.1007/s00198-017-4087-z pubmed: 28547134

Auteurs

Florian Dudde (F)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestraße 59, 22529, Hamburg, Germany.
Department of Periodontics, Preventive and Restorative Dentistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Dominik Fildebrandt (D)

Department of Periodontics, Preventive and Restorative Dentistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ralf Smeets (R)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Martin Gosau (M)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Michael Amling (M)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestraße 59, 22529, Hamburg, Germany.

Thomas Beikler (T)

Department of Periodontics, Preventive and Restorative Dentistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Florian Barvencik (F)

Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Lottestraße 59, 22529, Hamburg, Germany. fbarvencik@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH